Skip Navigation HRSA - U.S Department of Health and Human Services, Health Resources and Service Administration U.S. Department of Health & Human Services
Order Publications
Grants Find Help Service Delivery Data Health Care Concerns About HRSA

Pharmacy Affairs & 340B Drug Pricing Program

Office of Pharmacy Affairs

Effective October 15, the Office of Pharmacy Affairs (OPA) will resume normal operations for the addition of new sites. OPA will continue to verify and process completed covered entity registration forms until close of business on October 14. Any subsequent covered entity registration forms that are verified and processed after October 14 will begin participation in the 340B Program on 1/1/2009. The deadline for receipt of applications will be December 1 for those wishing to enroll by 1/1/2009. OPA would like to thank everyone for their cooperation during the public health emergency.


A component of the Health Resources and Services Administration Healthcare Systems Bureau, the Office of Pharmacy Affairs has three primary functions:

  • Administration of the 340B Drug Pricing Program, through which certain federally funded grantees and other safety net health care providers may purchase prescription medication at significantly reduced prices.
  • Development of innovative pharmacy services models and technical assistance.
  • Service as a federal resource about pharmacy.

In all of its activities, OPA emphasizes the importance of comprehensive pharmacy services being an integral part of primary health care.  Comprehensive pharmacy services include patient access to affordable pharmaceuticals, application of "best practices" and efficient pharmacy management and the application of systems that improve patient outcomes through safe and effective medication use.

Office of Pharmacy Affairs
5600 Fishers Lane,
Parklawn Building, Mail Stop 10C-03
Rockville, MD 20857

Current Issues Highlights

HRSA Endorses Recommendations for Adult Immunizations (November 19, 2008)

340B Prime Vendor Apexus Announces $2 Million Shareback Program for Eligible Participants (Nov. 14, 2008)

340B Prime Vendor Apexus Enlists Standard Register to Help 340B-qualified Healthcare Providers Fight Prescription Fraud and Improve Patient Safety (Acrobat/pdf) (October 15, 2008) Exit Disclaimer

US Department of Justice’s settlement with Cephalon – As part of the settlement, 340B Covered Entities will be receiving approximately $1.8 million. Cephalon Settlement Agreement and Cephalon News Release from DOJ (October 2, 2008)

Bayer Letter - Regarding the Yasmin® Limited Distribution System (September 30, 2008)

HRSA issues Medicaid Exclusion Tutorial and Medicaid Exclusion File Basics - March 2008

HRSA Patient Safety & Clinical Pharmacy Services Collaborative February 2008

More Current Issues